PRISM-PLUS糖尿病亚组研究PPT课件.pptVIP

PRISM-PLUS: Demographics of Patients With Diabetes Patients Without Patients With Diabetes Diabetes (n=1208) (n=362) PRISM-PLUS: MI/Death Outcomes in Patients With Diabetes PRISM-PLUS: MI in Patients With Diabetes PRISM-PLUS: Results in Patients With Diabetes Conclusion Tirofiban + heparin therapy resulted in a marked sustained reduction in major cardiac outcomes, particularly recurrent MI, in patients with diabetes presenting with UAP/NQWMI. Mean age (y) 62 66 Prior MI 40% 47% Heart failure 7% 16% PTCA 31% 28% CABG 23% 24% % Patients 9.3% 1.2% P=0.004 15.5% 4.7% P=0.002 1